Tracing hypoxic state and hypoxia memory in glioblastoma progression
追踪胶质母细胞瘤进展中的缺氧状态和缺氧记忆
基本信息
- 批准号:10387061
- 负责人:
- 金额:$ 25.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-12-15 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAcuteAddressAftercareCancer PrognosisCell HypoxiaCell LineCellsComplementCoupledDataDiffuseDiphtheria ToxinEnvironmentExperimental DesignsExposure toFluorescenceGene Expression ProfileGene Expression ProfilingGenesGeneticGenetic TranscriptionGlioblastomaGliomaGoalsGreen Fluorescent ProteinsGrowthHistologicHypoxiaHypoxia Inducible FactorImmune responseImmunocompetentInfiltrationLinkMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of brainMapsMemoryModelingMolecularMolecular ProfilingMolecular TargetMusNecrosisOutcomeOxygenPatientsPatternPhysiologic pulsePopulationPrimary Brain NeoplasmsPrognosisRadiation therapyRecording of previous eventsRecurrenceRelapseReporterReportingResponse ElementsRoleSCID MiceSpatial DistributionStress and CopingSystemTamoxifenTestingTherapeuticTimeTracerTransplant RecipientsTransplantationTumor Tissuealpha Toxinangiogenesisbasecombatdesignfitnessfluorophoregenetic approachinnovationinsightmetabolic fitnessmigrationneoplastic cellprognostic toolprogramspromoterrelease factorresponsesingle-cell RNA sequencingstem cellsstemnesstherapeutic targettransplant modeltumortumor hypoxiatumor progressiontumorigenic
项目摘要
Hypoxia is linked to worse prognosis for cancers, including glioblastoma (GBM), the most common and highly
lethal primary brain tumor. Hypoxic tumor cells are thought to be better equipped to survive therapy and spawn
tumor recurrence, however, the trajectory of hypoxic cells during GBM expansion and their roles in recurrent
GBM after therapy remain poorly understood. The main goal of this proposal is to apply a dual genetically
encoded hypoxia-sensitive reporter system with lineage tracing capability to systematically characterize hypoxic
tumor cells during GBM progression. The dual reporter system distinguishes tumor cells that are acutely hypoxic
(marked by green fluorescence) from those with a history of hypoxia exposure (permanently marked with red
fluorescence). Their cell fate will be traced across time and space during GBM progression in both primary and
recurrent GBM models. The cellular study will be coupled with gene expression analysis on single cell level to
unravel the molecular underpinning of malignant potency of hypoxic tumor cells. By comparing transcription
profiles of acutely hypoxic versus hypoxia-exposed cells in primary and recurrent GBM, we will test the
hypothesis that there exists a hypoxia memory, i.e., hypoxia-exposed cells retaining a set of hypoxia-induced
genes that may be linked to survival fitness and tumorigenic potential. In conjunction to the descriptive part of
our study, we have also devised a genetic platform to selectively ablate hypoxic population with temporal control
to study their contribution to tumor progression in both primary and recurrent GBM. This functional data will
provide direct evidence to test the central hypothesis that hypoxia contributes to tumor progression, and more
importantly, tumor relapse after treatment. In summary, our innovative study will gain new insights into the link
between hypoxia and GBM malignancy, and set the stage for the discovery of new prognostic tools and
therapeutics targets to combat GBM.
缺氧与癌症的预后不良有关,包括胶质母细胞瘤(GBM),这是最常见和高度恶性的肿瘤。
致命的原发性脑瘤低分化的肿瘤细胞被认为是更好的装备,以生存治疗和产卵
然而,肿瘤复发,GBM扩张期间缺氧细胞的轨迹及其在复发中的作用,
治疗后的GBM仍然知之甚少。这项建议的主要目标是应用一种双重基因,
具有谱系追踪能力的编码缺氧敏感性报告系统
GBM进展过程中的肿瘤细胞。双报告系统区分急性缺氧的肿瘤细胞
(用绿色荧光标记)与有缺氧暴露史的人(用红色永久标记)比较
荧光)。它们的细胞命运将在原发性和继发性GBM进展期间跨时间和空间追踪。
复发性GBM模型。细胞研究将与单细胞水平的基因表达分析相结合,
解开缺氧肿瘤细胞恶性潜能的分子基础。通过比较转录
在原发性和复发性GBM中急性缺氧与缺氧暴露细胞的概况,我们将测试
假设存在缺氧记忆,即,缺氧暴露的细胞保留一组缺氧诱导的
可能与生存适应性和肿瘤发生潜力有关的基因。在结合的描述部分,
在我们的研究中,我们还设计了一个遗传平台,通过时间控制来选择性地消融缺氧群体。
研究它们对原发性和复发性GBM中肿瘤进展的贡献。这些功能数据将
提供直接证据来检验缺氧促进肿瘤进展的中心假设,等等。
重要是,治疗后肿瘤复发。总之,我们的创新研究将对这一联系有新的认识
缺氧和GBM恶性肿瘤之间的关系,并为发现新的预后工具奠定基础,
治疗靶点来对抗GBM。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roland Horst Friedel其他文献
Roland Horst Friedel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roland Horst Friedel', 18)}}的其他基金
Dissect regulation of glial nets surrounding amyloid plaques in Alzheimer's disease
剖析阿尔茨海默病中淀粉样斑块周围神经胶质网的调节
- 批准号:
10467139 - 财政年份:2022
- 资助金额:
$ 25.36万 - 项目类别:
Tracing Hypoxic State and Hypoxia Memory in Glioblastoma Progression
追踪胶质母细胞瘤进展中的缺氧状态和缺氧记忆
- 批准号:
10541195 - 财政年份:2021
- 资助金额:
$ 25.36万 - 项目类别:
Plexin-B2 Function in Glioma Invasion
Plexin-B2 在神经胶质瘤侵袭中的功能
- 批准号:
10296785 - 财政年份:2016
- 资助金额:
$ 25.36万 - 项目类别:
Plexin-B2 function in glioma invasion and glioma stem cell maintenance
Plexin-B2 在神经胶质瘤侵袭和神经胶质瘤干细胞维持中的功能
- 批准号:
9900877 - 财政年份:2016
- 资助金额:
$ 25.36万 - 项目类别:
Plexin-B2 function in glioma invasion and glioma stem cell maintenance
Plexin-B2 在神经胶质瘤侵袭和神经胶质瘤干细胞维持中的功能
- 批准号:
9106872 - 财政年份:2016
- 资助金额:
$ 25.36万 - 项目类别:
Plexin-B2 Function in Glioma Invasion
Plexin-B2 在神经胶质瘤侵袭中的功能
- 批准号:
10655424 - 财政年份:2016
- 资助金额:
$ 25.36万 - 项目类别:
Tracking the in vivo proliferative history of human glioma-derived stem cells
追踪人胶质瘤干细胞的体内增殖史
- 批准号:
8622863 - 财政年份:2013
- 资助金额:
$ 25.36万 - 项目类别:
Tracking the in vivo proliferative history of human glioma-derived stem cells
追踪人胶质瘤干细胞的体内增殖史
- 批准号:
8742022 - 财政年份:2013
- 资助金额:
$ 25.36万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 25.36万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 25.36万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 25.36万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 25.36万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 25.36万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 25.36万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 25.36万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 25.36万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 25.36万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 25.36万 - 项目类别:
Standard Grant














{{item.name}}会员




